HO-1 and CD39: It Takes Two to Protect the Realm

被引:16
|
作者
Lee, Ghee Rye
Shaefi, Shahzad
Otterbein, Leo E. [1 ]
机构
[1] Harvard Med Sch, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
来源
FRONTIERS IN IMMUNOLOGY | 2019年 / 10卷
关键词
heme; innate immunity; adenosine; metabolism; bioenergetics; HEME OXYGENASE-1 EXPRESSION; CARBON-MONOXIDE; EXTRACELLULAR ATP; SERUM BILIRUBIN; BILIVERDIN PROTECTS; INDUCE TOLERANCE; MURINE COLITIS; BILE-PIGMENTS; CELLULAR IRON; TISSUE-INJURY;
D O I
10.3389/fimmu.2019.01765
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cellular protective mechanisms exist to ensure survival of the cells and are a fundamental feature of all cells that is necessary for adapting to changes in the environment. Indeed, evolution has ensured that each cell is equipped with multiple overlapping families of genes that safeguard against pathogens, injury, stress, and dysfunctional metabolic processes. Two of the better-known enzymatic systems, conserved through all species, include the heme oxygenases (HO-1/HO-2), and the ectonucleotidases (CD39/73). Each of these systems generates critical bioactive products that regulate the cellular response to a stressor. Absence of these molecules results in the cell being extremely predisposed to collapse and, in most cases, results in the death of the cell. Recent reports have begun to link these two metabolic pathways, and what were once exclusively stand-alone are now being found to be intimately interrelated and do so through their innate ability to generate bioactive products including adenosine, carbon monoxide, and bilirubin. These simple small molecules elicit profound cellular physiologic responses that impact a number of innate immune responses, and participate in the regulation of inflammation and tissue repair. Collectively these enzymes are linked not only because of the mitochondria being the source of their substrates, but perhaps more importantly, because of the impact of their products on specific cellular responses. This review will provide a synopsis of the current state of the field regarding how these systems are linked and how they are now being leveraged as therapeutic modalities in the clinic.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] CD39/CD73 Expressing Exosomes Protect Against Arterial Thrombosis
    Covarrubias, Roman
    Snoek, Susanne A.
    Zhong, Lin
    Broekstra, Niels
    Finn, Jonathan D.
    Gumina, Richard J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37
  • [2] Apyrase and CD39 signaling protect against sepsis-induced mortality
    Nemeth, Zoltan H.
    Csoka, Balazs
    Koscso, Balazs
    Kokai, Endre
    DiFazio, Louis T.
    Rolandelli, Rolando H.
    Hasko, Gyorgy
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (03) : S28 - S28
  • [3] CD39, NTPDase 1, is attached to the plasma membrane by two transmembrane domains. Why?
    Grinthal A.
    Guidotti G.
    Purinergic Signalling, 2006, 2 (2) : 391 - 398
  • [4] Thrombo-Inflammation: A Focus on NTPDase1/CD39
    Morello, Silvana
    Caiazzo, Elisabetta
    Turiello, Roberta
    Cicala, Carla
    CELLS, 2021, 10 (09)
  • [5] 心肺复苏成功患者血清HO-1、CD39水平与心功能、主要不良心血管事件的关系
    杨思伟
    袁圆
    宋训君
    国际检验医学杂志, 2024, 45 (16) : 2038 - 2043
  • [6] Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection
    Marcus, AJ
    Broekman, MJ
    Drosopoulos, JHF
    Olson, KE
    Islam, N
    Pinsky, DJ
    Levi, R
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2005, 31 (02): : 234 - 246
  • [7] ENTPD1/CD39 is a promising therapeutic target in oncology
    Bastid, J.
    Cottalorda-Regairaz, A.
    Alberici, G.
    Bonnefoy, N.
    Eliaou, J-F
    Bensussan, A.
    ONCOGENE, 2013, 32 (14) : 1743 - 1751
  • [8] CD39/NTPDase-1 activity and expression in normal leukocytes
    Pulte, E. Dianne
    Broekman, M. Johan
    Olson, Kim E.
    Drosopoulos, Joan H. F.
    Kizer, Jorge R.
    Islam, Naziba
    Marcus, Aaron J.
    THROMBOSIS RESEARCH, 2007, 121 (03) : 309 - 317
  • [9] ENTPD1/CD39 is a promising therapeutic target in oncology
    J Bastid
    A Cottalorda-Regairaz
    G Alberici
    N Bonnefoy
    J-F Eliaou
    A Bensussan
    Oncogene, 2013, 32 : 1743 - 1751
  • [10] HO-1 polimorphysm protect against chronic allograft nephropathy progression.
    Ozaki, Kikumi S.
    Marques, Georgia M.
    Nogueira, Eliana
    Feitosa, Renato Q.
    Cenedese, Marco A.
    Bach, Fritz H.
    Soares, Miguel
    Camara, Niels O. S.
    Pacheco-Silva, Alvaro
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 352 - 352